Similar approaches assessing the combinatorial effect of IL‐24 and radiation therapy have been employed in in vivo xenograft models of melanoma (Jiang et al. 2012), glioma (Yacoub, Mitchell, Lister, et al. 2003) and breast cancer (Chada et al. 2006). The gene discussed is IL24; the disease is melanoma.